Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsRADICAVA

RADICAVA

Biotechnology

Mitsubishi Tanabe Pharma America Announces FDA Acceptance of New Drug Application (NDA) for Oral Edaravone Formulation for the Treatment of ALS

PR Newswire -
Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us